Similar articles

• Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.

  Di Lullo L, Ronco C, Cozzolino M, Russo D, Russo L, Di Iorio B, De Pascalis A, Barbera V, Galliani M, Vitaliano E, Campana C, Santoboni F, Bellasi A. Di Lullo L, et al. Thromb Res. 2017 Jul;155:38-47. doi: 10.1016/j.thromres.2017.04.027. Epub 2017 May 4. Thromb Res. 2017. PMID: 28482261 Review.
• Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

  Olesen JB, Sørensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, Køber L, Gislason GH, Torp-Pedersen C, Fosbøl EL. Olesen JB, et al. Europace. 2015 Feb;17(2):187-93. doi: 10.1093/europace/euu225. Epub 2014 Sep 18. Europace. 2015. PMID: 25236181
• Chronic Kidney Disease as Basis of High Thrombotic and Bleeding Risk in Patients With Atrial Fibrillation: Place of Oral Anticoagulants.

  Obrezan AG, Zemchenkov AY. Obrezan AG, et al. Kardiologiia. 2018 Nov 18;58(4):60-70. doi: 10.18087/cardio.2018.4.10111. Kardiologiia. 2018. PMID: 30704384
• Anticoagulation in chronic kidney disease patients with atrial fibrillation: old vs new drugs.

  Jędras M, Dębowska M, Staszków M. Jędras M, et al. Wiad Lek. 2019;72(11 cz 2):2214-2217. Wiad Lek. 2019. PMID: 31860839
• [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].

  Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C. Di Lullo L, et al. G Ital Nefrol. 2017 Apr;34(2):58-73. G Ital Nefrol. 2017. PMID: 28682563 Review. Italian.